Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...
Me turns research into useful genetic insights, now offering a new GLP-1 report and interactive tool through 23andMe Total ...
A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...
Distinct GLP1R and GIPR variants correlated with nausea/vomiting risk, with a GIPR signal appearing tirzepatide-specific and showing markedly increased vomiting odds. New studies from 23andMe suggest ...
Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...
New findings could partially help explain why some people appear to lose weight more quickly than others while taking the ...
Structural variants (SVs) are alterations in the DNA sequence that involve large-scale changes, typically longer than 50 base pairs. Advances in long-read sequencing have significantly increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results